RecruitingNot ApplicableNCT05426408

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3 - Pilot Study of Prevalence of Coronary Microvascular Dysfunction in Myocardial Infarction with Nonobstructive Coronary Arteries

Sponsor

Karolinska Institutet

Enrollment

85 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

Myocardial Infarction With Nonobstructive Coronary Arteries

Summary

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Eligibility

Min Age: 35 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Cardiac magnetic resonance imaging to study coronary microvascular dysfunction for people with myocardial infarction with nonobstructive coronary arteries. The study is currently recruiting participants at 1 location. People eligible for this study include aged 35 Years to 79 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCardiac magnetic resonance imaging to study coronary microvascular dysfunction

Myocardial perfusion mapping will be investigated after administration of adenosine

Locations(1)

Per Tornvall

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05426408

Related Trials

Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.

NCT051987912 locations